Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Normal Human
100%
Agonist Activity
100%
Human Volunteers
100%
Serum Prolactin
100%
Kappa Opioid
100%
Nalmefene
100%
Kappa Opioid Receptor
50%
Dopamine
25%
μ-opioid Receptor
25%
Placebo
16%
Partial Agonist
16%
Prolactin
16%
Kappa Opioid Receptor Agonist
16%
Tuberoinfundibular
16%
Healthy Volunteers
8%
Alcohol Dependence
8%
Chinese Hamster Ovary Cells
8%
Intravenous Infusion
8%
Blood Specimen
8%
In Vitro Study
8%
Cocaine Dependence
8%
Brain Regions
8%
Therapeutic Efficacy
8%
Substance Use Disorder
8%
μ-Opioid Receptor Agonist
8%
Serum Levels
8%
Kappa Agonist
8%
Binding Studies
8%
Selective Antagonist
8%
Addictive Behavior
8%
Opioid Receptor Activation
8%
Binding Assay
8%
Prolactin Release
8%
Unexpected Findings
8%
Opioid Antagonism
8%
Psychiatric Medication Use
8%
Pharmacology, Toxicology and Pharmaceutical Science
Normal Human
100%
Nalmefene
100%
Kappa Opiate Receptor Agonist
100%
Prolactin
100%
Kappa Opiate Receptor
50%
μ-Opioid Receptor
25%
Dopamine
25%
Placebo
16%
Partial Agonist
16%
Biological Marker
8%
Drug Dependence
8%
Cocaine Dependence
8%
Sulfur 35
8%
Mu Opiate Receptor Agonist
8%
Chinese Hamster
8%
Diseases
8%
Alcoholism
8%
Neuroscience
Prolactin
100%
Nalmefene
100%
Agonist
100%
Kappa Opiate Receptor
66%
μ-Opioid Receptor
33%
Dopamine
25%
Receptor Agonists
16%
Placebo
16%
Physical Dependence
8%
Kappa Agonists
8%
In Vitro
8%
Cocaine Dependence
8%
Brain Region
8%
Biological Marker
8%
Alcoholism
8%